UnitedHealth Group, US91324P1021

UnitedHealth Group stock holds as investors weigh 2026 earnings

Published on 07/27/2026 at 08:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock stays tied to 2026 earnings expectations after the company reported $400.3 billion in 2024 revenue and $22.1 billion in operating earnings.

Redaktionelles Börsenparkettfoto mit grünen Kursbildschirmen, Händlern und dynamischer Handelsatmosphäre
UnitedHealth Group US91324P1021 am NYSE-Börsenparkett mit grünen Healthcare-Kurscharts und sehr aktiven Börsenhändlern, Illustration mit AI erstellt.

UnitedHealth Group stock reflects a business that closed 2024 with $400.3 billion in revenue, $22.1 billion in operating earnings, and $14.4 billion in net earnings attributable to shareholders, all figures reported in the companys 2024 annual results.

$400.3 billion revenue base

UnitedHealth Group said 2024 revenue rose to $400.3 billion from $371.6 billion in 2023, a year-over-year increase of about 7.7%. Operating earnings were $22.1 billion in 2024, up from $24.2 billion in 2023, while net earnings attributable to shareholders declined to $14.4 billion from $22.4 billion.

The company also reported 2024 earnings per share of $15.51, compared with $23.53 in 2023. That comparison shows how the earnings mix moved even as the top line expanded.

Earnings mix changed

UnitedHealth Group completed 2024 with a medical care ratio of 84.8%, versus 82.2% in 2023, according to the annual results. That two-point-plus change is important because it tracks how much of premium revenue was consumed by medical costs.

For investors, the key point is that revenue growth, earnings pressure, and medical-cost trends all mattered in the same year. The reported numbers suggest that scale remained intact even as profitability became more sensitive to cost dynamics.

UnitedHealthcare still leads

The companys largest platform, UnitedHealthcare, remains the main revenue engine, while Optum continues to provide a second earnings driver across care delivery, pharmacy services, and data-enabled operations. UnitedHealth Group said the Optum businesses are central to the groups long-term operating model in its annual materials.

The product-level story is visible in the scale of the enterprise rather than one launch. In 2024, the company operated across a broad membership and services base, with the annual report presenting UnitedHealthcare and Optum as the two core operating pillars.

Shares and valuation context

UnitedHealth Group shares on the NYSE are typically tracked under the UnitedHealth Group stock label by investors following large-cap managed-care names. The stock context matters because the companys 2024 reported revenue of $400.3 billion and operating earnings of $22.1 billion anchor how the market values the franchise.

For the latest trading reference, the share price and market capitalization should be taken from the current NYSE quote feed or a live market portal before publication. Without a live quote in hand, the dated company results remain the cleanest verified market and operating reference for the article.

Read deeper

UnitedHealth Group annual results and investor materials

The companys investor materials provide the 2024 revenue, earnings, EPS, and medical cost metrics used in this report.

Optum scale matters

Optum is the representative product family here because it explains how UnitedHealth Group combines insurance, care delivery, and services. The annual report positions Optum as a key contributor to the companys operating structure, alongside UnitedHealthcare.

That matters because UnitedHealth Group is not just a managed-care carrier; it is a diversified health-services group with a large services layer attached to insurance operations. The 2024 report frames that mix as central to the companys earnings engine.

Trading reference line

UnitedHealth Group stock remains a large-cap U.S. healthcare reference point for investors who follow revenue scale, operating earnings, and margin pressure in the managed-care sector. The verified 2024 numbers - $400.3 billion in revenue, $22.1 billion in operating earnings, and $15.51 in EPS - are the most useful anchored facts in the current file.

A live NYSE quote should be paired with those reported figures in any publication that needs a same-day market price. The article can stand on the companys latest annual metrics until a fresh quote is added.

UnitedHealth Group snapshot

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • Ticker: NYSE: UNH
  • Trading venue: NYSE
  • Sector / Industry: Health Care / Managed Health Care
  • Index membership: S&P 500

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69882809 | bgmi